https://pharmatlas.org/ 2026-04-06T07:37:00+00:00 https://pharmatlas.org/ https://pharmatlas.org/lib/exe/fetch.php?media=logo.png text/html 2026-02-13T00:37:01+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:tzds:pioglitazone&rev=1770943021&do=diff Pioglitazone Pioglitazone is a thiazolidinedione (TZD) that improves insulin sensitivity through activation of the PPAR-γ nuclear receptor. It is the most commonly used TZD. → Thiazolidinediones (TZDs) ---------- Mechanism of Action Pioglitazone activates: * Peroxisome proliferator-activated receptor gamma (PPAR-γ) text/html 2026-02-13T00:36:26+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:tzds:rosiglitazone&rev=1770942986&do=diff Rosiglitazone Rosiglitazone is a thiazolidinedione (TZD) that improves insulin sensitivity through activation of the PPAR-γ nuclear receptor. → Thiazolidinediones (TZDs) ---------- Mechanism of Action Rosiglitazone activates: * Peroxisome proliferator-activated receptor gamma (PPAR-γ) text/html 2026-02-13T00:35:49+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:tzds:start&rev=1770942949&do=diff Thiazolidinediones (TZDs) Thiazolidinediones are insulin sensitizers that improve peripheral glucose uptake by activating the PPAR-γ nuclear receptor. They are antihyperglycemic agents with low intrinsic hypoglycemia risk. ---------- Mechanism of Action